DPIIT recognised startup Government of India
Startup India
Inger Therapeutics Private Limited - healthcare in Tiruvallur, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹60.42 Lakh
▲ 127% YoY
Net profit · FY 2024
₹94,875
Net margin 1.6%
EBITDA · FY 2024
₹94,875
EBITDA margin 1.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Brands
1
Associated brands
About Inger Therapeutics Private Limited
Data last updated:
Inger Therapeutics Private Limited is a private limited company based in Tiruvallur, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the medical and surgical equipment segment of the healthcare sector. It was incorporated on 28 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33119TN2021PTC147484.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Bala Yeshwanth Ram Vummidi and Surekha Vummidi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Old.No.16 New.No.29 Gandhi Road, Tiruvallur, Tamil Nadu, India – 602001.
As per the financials filed for FY 2024, the company reported a revenue of ₹60.42 Lakh, a growth of 127% compared to the previous year. For the same year it recorded a net profit of ₹94,875 (net margin 1.6%) and EBITDA of ₹94,875 (EBITDA margin 1.6%).
The company is associated with 1 brand: Inger Therapeutics.
For more details, the company can be reached via its website ingertx.com.
Company details
CIN U33119TN2021PTC147484
Registration Number 147484
Incorporation Date 28 October 2021
ROC Chennai
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Inger Therapeutics
Contact details
Inger Therapeutics Private Limited's registered office is in Tiruvallur, Tamil Nadu. Its website is ingertx.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressOld.No.16 New.No.29 Gandhi Road, Tiruvallur, Tamil Nadu, India – 602001
- IndustryHealthcare, Medical & Surgical Equipment, Manufacturing, Orthopedic Appliances, Other Medical And Surgical Equipment, Medical Appliances And Instruments
To see the full contact details of Inger Therapeutics Private Limited, buy the company report.
Comprehensive company report
Inger Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Inger Therapeutics operates one associated brand: Inger Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Suprabodies are developed as peptide-based therapeutics for research applications. | ingertx.com |
Business activity
The main business activity of Inger Therapeutics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Inger Therapeutics Private Limited, buy the company report.
Financials of Inger Therapeutics Private Limited
FY 2025 filings availableInger Therapeutics Private Limited reported revenue of ₹60.42 Lakh (up 127% YoY) for FY 2024.
Revenue · FY 2024
₹60.42 Lakh ▲ 127%
Net profit · FY 2024
₹94,875 margin 1.6%
EBITDA · FY 2024
₹94,875 margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 127%
EBITDA CAGR growth
1 year
▲ 150%
Revenue rose 127% in the latest year. EBITDA rose 150% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹94,875 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹94,875 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.6% | ||
| Net Profit Margin | 1.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Inger Therapeutics Private Limited, buy the company report.
Board of directors of Inger Therapeutics Private Limited
Inger Therapeutics has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bala Yeshwanth Ram Vummidi | Director | 28 Oct 2021 | 5 Years 0 Months | Current |
| Surekha Vummidi | Director | 28 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Inger Therapeutics Private Limited is compared with the 7 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| PFC Pharma Focus India Private Limited | ₹60.98 Lakh (FY 2024) | -42.0% | New Delhi, Delhi, India | |||
| DFM Research Labs Private Limited | ₹60.62 Lakh (FY 2025) | 11.0% | Pune, Maharashtra, India | |||
| Center for Research On Molecular and Applied Sciences Private Limited | ₹60.44 Lakh (FY 2025) | 51.0% | Thiruvananthapuram, Kerala, India | |||
| Inger Therapeutics Private Limitedthis company | ₹60.42 Lakh (FY 2024) | ₹94,875 | 1.6% | 127.0% | Tiruvallur, Tamil Nadu, India | |
| Calyan Cardiac Therapeutics India Private Limited | ₹60.32 Lakh (FY 2024) | -59.0% | Chennai, Tamil Nadu, India | |||
| Dextrose Technologies Private Limited | ₹59.99 Lakh (FY 2025) | 79.0% | Bangalore, Karnataka, India | |||
| Mouktik Consulting Services Private Limited | ₹59.96 Lakh (FY 2024) | -88.0% | Hyderabad, Telangana, India | |||
| Indian Institute of Integrative Medicine-Technology Business Incubator (III | ₹59.57 Lakh (FY 2024) | 111.0% | Jammu, Jammu and Kashmir, India |
To see the full peer comparison of Inger Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inger Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inger Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Inger Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Inger Therapeutics Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Bala Yeshwanth Ram Vummidi was appointed as Director on 28 Oct 2021.
AGM
Inger Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Inger Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Bala Yeshwanth Ram Vummidi was appointed as Director.
Appointed
Surekha Vummidi was appointed as Director.
Incorporation
28 Oct 2021
Inger Therapeutics Private Limited was registered on 28 Oct 2021 with Roc Chennai & aged 5 years 16 days as per MCA records.
Frequently asked questions
Inger Therapeutics is an active private limited company based in Tiruvallur, Tamil Nadu, India. The company works in medical and surgical equipment, within the healthcare industry. It was incorporated on 28 October 2021 (5+ years old) and is registered under CIN U33119TN2021PTC147484.
Inger Therapeutics has 2 current directors:
- Bala Yeshwanth Ram Vummidi - Director
- Surekha Vummidi - Director
The latest financial statements of Inger Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Inger Therapeutics is U33119TN2021PTC147484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inger Therapeutics was incorporated on 28 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Inger Therapeutics by revenue are PFC Pharma Focus India Private Limited, DFM Research Labs Private Limited, Center for Research On Molecular and Applied Sciences Private Limited, Calyan Cardiac Therapeutics India Private Limited, Dextrose Technologies Private Limited and 2 more, all in the same principal business activity (scientific research and development).
Bala Yeshwanth Ram Vummidi was appointed as Director on 28 Oct 2021. Surekha Vummidi was appointed as Director on 28 Oct 2021.
Yes, Inger Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Inger Therapeutics can be reached through the website ingertx.com. Its registered office is in Tiruvallur, Tamil Nadu, India.
The registered office of Inger Therapeutics is at Old.No.16 New.No.29 Gandhi Road, Tiruvallur, Tamil Nadu, India – 602001.
Inger Therapeutics operates in the healthcare industry, in the medical and surgical equipment segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages